Steven Cohen Arcutis Biotherapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 830,478 shares of ARQT stock, worth $10.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

830,478

Previous 1,753,522 52.64%

Holding current value

$10.8 Million

Previous $24.4 Million 46.83%

% of portfolio

0.03%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$11.4 - $17.29 $10.5 Million - $16 Million	-923,044 Reduced 52.64%	830,478 $13 Million
Q4 2024 Feb 14, 2025	BUY	$8.31 - $14.99 $12.5 Million - $22.6 Million	1,509,136 Added 617.52%	1,753,522 $24.4 Million
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $2.03 Million - $2.69 Million	244,386 New	244,386 $2.27 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $589,352 - $1.54 Million	320,300 New	320,300 $1.03 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $11.3 Million - $18.9 Million	-1,103,576 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$13.96 - $20.4 $37.4 Million - $54.7 Million	-2,681,701 Reduced 70.85%	1,103,576 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $32.1 Million - $48.5 Million	1,797,846 Added 90.46%	3,785,277 $72.3 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $4.73 Million - $6.43 Million	289,582 Added 17.06%	1,987,431 $42.4 Million
Q1 2022 May 16, 2022	SELL	$14.38 - $22.79 $13.6 Million - $21.6 Million	-946,328 Reduced 35.79%	1,697,849 $32.7 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $9.77 Million - $16.6 Million	652,070 Added 32.73%	2,644,177 $54.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $21.1 Million - $29.7 Million	1,095,707 Added 122.23%	1,992,107 $47.6 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $11.2 Million - $15.9 Million	457,100 Added 104.05%	896,400 $24.5 Million
Q1 2021 May 17, 2021	SELL	$24.47 - $36.98 $10.7 Million - $16.1 Million	-435,900 Reduced 49.81%	439,300 $12.7 Million
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $14.8 Million - $26.4 Million	831,944 Added 1923.3%	875,200 $24.6 Million
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $1.01 Million - $1.4 Million	43,256 New	43,256 $1.27 Million

Others Institutions Holding ARQT

# of Institutions

251

Shares Held

126M

Call Options Held

605K

Put Options Held

170K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $785M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account